{
    "title": "US FDA approves Opiant's spray for reversing opioid-related overdoses",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12112855/US-FDA-approves-Opiants-spray-reversing-opioid-related-overdoses.html",
    "date": "2023-05-22",
    "keywords": [
        "drug",
        "spray",
        "health",
        "administration",
        "treatment",
        "approval",
        "use",
        "indivior",
        "regulator",
        "year",
        "food",
        "countrys",
        "fight",
        "crisis",
        "addiction",
        "drugmaker",
        "plc",
        "opiant",
        "deal",
        "brand",
        "name",
        "opvee",
        "naloxone",
        "medication",
        "prescription",
        "care",
        "community",
        "agency",
        "sale",
        "nasal",
        "owner",
        "royalty",
        "payment",
        "emergent",
        "product",
        "government",
        "access",
        "application",
        "study",
        "reversal",
        "respiratory",
        "depression",
        "dose",
        "form",
        "companys",
        "profit",
        "launch",
        "nasdaq",
        "june",
        "reporting",
        "bhanvi",
        "satija",
        "vaibhav",
        "sadhamta",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}